Business Standard
Home / India News / Shasun Pharma acquires global rights of Ibuprofen & Nuprin trademark

Shasun Pharma acquires global rights of Ibuprofen & Nuprin trademark

Image

Capital Market
Last Updated : May 06 2014 | 12:05 AM IST

From ScolrPharma, USA

Shasun Pharmaceuticals has acquired the global rights from ScolrPharma, USA, to develop and commercialise Ibuprofen 12 hour extended release OTC tablets as well as the associated controlled release technology (CDT) along with global rights of Nuprin trademark, a well known brand in Analgesics.

Powered by Capital Market - Live News

Also Read

Tina Fey named new face for Garnier's new skincare line

Tina Fey named new face for Garnier's new skincare line

Meet the 'one-legged' teen footballer who had climbed Mt. Kilimanjaro on crutches when 13!

Meet the 'one-legged' teen footballer who had climbed Mt. Kilimanjaro on crutches when 13!

David Letterman to retire from CBS' 'Late Show' next year

David Letterman to retire from CBS' 'Late Show' next year

Meet the US couple who won 3 lotteries in a month

Meet the US couple who won 3 lotteries in a month

E.coli superbug just one gene away from becoming untreatable

E.coli superbug just one gene away from becoming untreatable

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 05 2014 | 1:29 PM IST

Explore News

Market LIVEMarket TodayIndia vs Pakistan LIVEParliament Winter Session 2024 LIVELatest News LIVEStocks To Watch TodayProcess to withdraw PF by ATMGold-Silver Price TodayIPO NewsBusiness Standard at 50
HOT STOCKS
TOP SECTIONS
KEY EVENTS
Copyrights © 2024 Business Standard Private Ltd. All rights reserved
LinkedIN Icon